Rachel Fuller Brown, a biochemist, and Elizabeth Lee Hazen, a microbiologist, were co-discoverers in 1950 of the drug nystatin, the first antibiotic administered to humans that safely and effectively treats serious fungal diseases. Both were employed by the Division of Laboratories and Research of the New York State Department of Health, Brown in Albany and Hazen in New York City. Brown and Hazen assigned patent royalities to the Research Corporation of New York, an non-profit foundation for the advancement of science. One-half the proceeds were designated for the general purposes of the Research Corporation, and one-half for the Brown-Hazen Fund, which supported research in the biomedical sciences.
From the description of Papers of Rachel Brown and Elizabeth Hazen, 1936-1983. (Harvard University). WorldCat record id: 733096395
